The Cancer Testing Access Bill aims to improve access to important cancer diagnostic tests for patients covered by Medicare and Medicaid. It helps ensure that individuals diagnosed with cancer can get the testing they need without facing excessive costs.
Critical Mineral Consistency Act of 2025This bill modifies the Energy Act of 2020 to expand the definition of critical minerals to include critical materials designated by the Department of Energy (DOE). Under current law, DOE's critical materials list contains certain materials that are essential for energy, including those on the critical minerals list of the U.S. Geological Survey (USGS). The USGS's list, which contains certain minerals that are essential to the nation's economic or national security, is not required to include the materials on DOE's list. Currently, both lists include minerals with a high risk of supply chain disruptions, and both DOE and USGS must conduct a variety of efforts to ensure a secure and reliable supply chain of the minerals. By expanding the definition of critical minerals, this bill requires the USGS to include on its list the materials on DOE's list. Within 45 days of DOE adding a mineral, element, substance, or material to its critical materials list, the USGS must update its list to include such mineral, element, substance, or material.
1. This bill allows Medicare to cover certain cancer diagnostic tests. 2. It defines cancer diagnostic tests to include advanced genetic testing methods. 3. Medicare will pay for these tests at 80% or 100% in some cases. 4. The bill also includes cancer diagnostic tests under Medicaid coverage. 5. It ensures patients can receive necessary tests without high out-of-pocket costs.